Список литературы

1. Wilkinson E.J., Teixeira M.R. Tumors of the vulva//Tavassoli F.A., Devilee P. (eds.). Pathology and genetics of tumors of the breast and female genital organs. - Lyon: IARC Press, 2003. - P. 314 - 334.

2. Jemal A, Tiwani RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer Statistics 2004. CA Cancer J Clin 2004; 54: 8 - 29.

3. Modesitt SC, Waters AB, Walton L, et al. Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence. Obstet Gynecol 1998; 92: 962 - 966.

4. Hacker NF. Vulvar cancer. In: Berek JS, Hacker NF, eds. Berek and Hacker's Gynecologic Oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2009, pp. 536 - 75.

5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7 - 30.

6. Коржевская Е.В., Кузнецов В.В. Злокачественные опухоли вульвы./Лекции по онкогинекологии. Под общей редакцией М.И. Давыдова, В.В. Кузнецова, под редакцией В.М. Нечушкинов. - Москва, "МЕДпресс-информ", 2009. - С. 174 - 193.

7. Кузнецов В.В., Коржевская Е.В. Плоскоклеточный рак вульвы./Рациональная фармакотерапия в онкологии: Руководство для практикующих врачей под общей ред. Академика РАН М.И. Давыдова, профессора В.А. Горбуновой - М.: Издательство "Литтерра", 2015. - С. 441 - 444.

8. Коржевская Е.В., Кузнецов В.В. Рак вульвы./Клиническая онкогинекология: Руководство для врачей под ред. В.П. Козаченко - 2-е изд., перераб. и доп. - М.: "Издательство Бином", 2016. - С. 72 - 96.

9. Greer BE, Koh WJ. New NCCN Guidelines for Vulvar Cancer. J Natl Compr Canc Netw 2016; 14: 656 - 658. Greer BE, Koh WJ. New NCCN Guidelines for Vulvar Cancer. J Natl Compr Canc Netw 2016; 14: 656 - 658.

10. Kamran MW, O'Toole F, Meghen K, et al. Whole-body [18F]fluoro2deoxyglucose positron emission tomography scan as combined PETCT staging prior to planned radical vulvectomy and inguinofemoral lymphadenectomy for squamous vulvar cancer: a correlation with groin node metastasis. Eur J Gynaecol Oncol 2014; 35: 230 - 235.

11. Slomovitz BM, Coleman RL, Oonk MH, et al. Update on sentinel lymph node biopsy for early-stage vulvar cancer. Gynecol Oncol 2015; 138: 472 - 477.

12. Moore DH, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Moore%20DH%5BAuthor%5D&cauthor=true&cauthor_uid=22079361)Ali S, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Ali%20S%5BAuthor%5D&cauthor=true&cauthor_uid=22079361)Koh WJ et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. (https://www.ncbi.nlm.nih.gov/pubmed/?term=Koh%20WJ%5BAuthor%5D&cauthor=true&cauthor_uid=22079361)Gynecol Oncol. 2012 Mar; 124(3): 529-33. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

13. Mahner S, Jueckstock J, Hilpert FJ et. al. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. Natl Cancer Inst. 2015 Jan 24; 107(3). (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

14. Hallak S, Ladi L, Sorbe B. Prophylactic inguinal-femoral irradiation as an alternative to primary lymphadenectomy in treatment of vulvar carcinoma. Int J Oncol 2007; 31: 1077 - 1085. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

15. Petereit DG, Mehta MP, Buchler DA, Kinsella TJ. Inguinofemoral radiation of N0, N1 vulvar cancer may be equivalent to lymphadenectomy if proper radiation technique is used. Int J Radiat Oncol Biol Phys 1993; 27: 963 - 967. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

16. Byfield J.E., Calabro-Jones P., Klisak I., Kulhanian F. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X-rays Int J Radiat Oncol Biol Phys, 8 (1982), pp. 1923 - 1933. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

17. Moore DH, Thomas GM, Montana GS, et al. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 1998; 42: 79 - 85. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

18. Levin W., Goldberg G., Altaras M., Bloch B., Shelton M.G. The use of concomitant chemotherapy and radiotherapy prior to surgery in advanced stage carcinoma of the vulva Gynecol Oncol, 25 (1986), pp. 20 - 25. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

19. Thomas G., Dembo A., DePetrillo A. et al. Concurrent radiation and chemotherapy in vulvar carcinoma Gynecol Oncol, 34 (1989), pp. 263 - 267. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

20. Wahlen S.A., Slater J.D., Wagner R.J. et al. Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva Cancer, 75 (1995), pp. 2289 - 2294. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

21. Sebag-Montefiore D.J., McLean C., Arnott S.J. et al. Treatment of advanced carcinoma of the vulvawith chemoradiotherapy-can exenterative surgery be avoided? Int J Gynecol Cancer, 4 (1994), pp. 150 - 155. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

22. Greer BE, Koh WJ. New NCCN Guidelines for Vulvar Cancer. J Natl Compr Canc Netw 2016; 14: 656 - 658 (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

23. Mell L.K., Mundt A.J., Survey of IMRT use in the United States, 2004. Cancer. 2005. 104: 1296 - 1303 (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

24. Lim K., Small W., Pertelance L et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2011. 79: 348 - 355. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

25. Berek J.S., Heaps J.M., Fu Y.S., Juillard G.J., Hacker N.F. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva Gynecol Oncol, 42 (1991), pp. 197 - 201. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

26. Gerszten K., Selvaraj R.N., Kelley J., Faul C. Preoperative chemoradiation for locally advanced carcinoma of the vulva Gynecol Oncol, 99 (2005), pp. 640 - 644;. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

27. Eifel P.J., Morris M., Burke T.W., Levenback C., Gershenson D.M. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva Gynecol Oncol, 59 (1995), pp. 51 - 56. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

28. Jaakkola M., Rantanen V., Grenman S., Kulmala J., Grenman R. Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro Anticancer Res, 17 (1997), pp. 939 - 943. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

29. Raitanen M., Rantanen V., Kulmala J. et al. Paclitaxel combined with fractionated radiation in vitro: a study with vulvar squamous cell carcinoma cell lines Int J Cancer, 97 (2002), pp. 853 - 857. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

30. Raitanen M., Rantanen V., Kulmala J. et al. Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro Int J Cancer, 100 (2002), pp. 238 - 243. (https://www.ncbi.nlm.nih.gov/pubmed/22079361)

31. Gill BS, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Gill%20BS%5BAuthor%5D&cauthor=true&cauthor_uid=25868965)Bernard ME, (https://www.ncbi.nlm.nih.gov/pubmed/?term=Bernard%20ME%5BAuthor%5D&cauthor=true&cauthor_uid=25868965)Lin JF et al. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis. (https://www.ncbi.nlm.nih.gov/pubmed/?term=Lin%20JF%5BAuthor%5D&cauthor=true&cauthor_uid=25868965)Gynecol Oncol. 2015 Jun; 137(3): 365-72. (https://www.ncbi.nlm.nih.gov/pubmed/25868965)

32. Somerfield M., Padberg J.J., Pfister D. et al. ASCO Clinical Practice Guidelines: Progress, Pitfalls, and Prospects. J Clin Oncol, V4, N 4; 2000: 881 - 886. (https://www.ncbi.nlm.nih.gov/pubmed/25868965)